Skip to main content

Michael H. Salinger, MD

Original Contribution
08/01/2008
Suture-mediated closure devices have had extensive use for closure of arterial access sites using 6–8 French (Fr) sheaths.1 Some experience with suture closure for large vessel arterial access has been described as well.2,3 The utility of...
Suture-mediated closure devices have had extensive use for closure of arterial access sites using 6–8 French (Fr) sheaths.1 Some experience with suture closure for large vessel arterial access has been described as well.2,3 The utility of...
Suture-mediated closure devices...
08/01/2008
Journal of Invasive Cardiology
Review
03/29/2011
ABSTRACT: Over the last decade, significant developments have been made in the treatment of structural heart disease. Some of these techniques require placement of large arterial sheaths for device delivery. Optimal vascular access is...
ABSTRACT: Over the last decade, significant developments have been made in the treatment of structural heart disease. Some of these techniques require placement of large arterial sheaths for device delivery. Optimal vascular access is...
ABSTRACT: Over the last decade,...
03/29/2011
Journal of Invasive Cardiology
Tips and Techniques
05/21/2014
Surgical left atrial appendage (LAA) exclusion has a failure rate as high as 60% due to persistent residual flow in the LAA or large LAA remnants. We describe a novel technique for treatment of incomplete surgical LAA ligation, and define the...
Surgical left atrial appendage (LAA) exclusion has a failure rate as high as 60% due to persistent residual flow in the LAA or large LAA remnants. We describe a novel technique for treatment of incomplete surgical LAA ligation, and define the...
Surgical left atrial appendage...
05/21/2014
Journal of Invasive Cardiology
05/01/2016
We describe the novel use of a paclitaxel drug-coated balloon for the treatment of in-stent restenosis of the pulmonary veins.
We describe the novel use of a paclitaxel drug-coated balloon for the treatment of in-stent restenosis of the pulmonary veins.
We describe the novel use of a...
05/01/2016
Journal of Invasive Cardiology
Original Contribution
07/25/2017
We describe safe utilization of Surgiflo hemostatic gel matrix under fluoroscopic guidance against an inflated balloon in order to achieve closure of a fistulous tract from a femoral artery access site during TAVR. 
We describe safe utilization of Surgiflo hemostatic gel matrix under fluoroscopic guidance against an inflated balloon in order to achieve closure of a fistulous tract from a femoral artery access site during TAVR. 
We describe safe utilization of...
07/25/2017
Journal of Invasive Cardiology